We are working with pharma companies better than ever before, says top university patent dealmaker
In an exclusive interview, Adam Stoten, the of COO Oxford University Innovation - one of Europe’s largest tech transfer offices - explains the challenges of protecting and commercialising early-stage life sciences inventions
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.